PHARMACEUTICAL STUDY FOR THERAPY OF LUNG DISEASES USING HUMAN SOD GENE TRANSFORMED CELLS
使用人SOD基因转化细胞治疗肺部疾病的药物研究
基本信息
- 批准号:07557313
- 负责人:
- 金额:$ 0.9万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1996
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Purpose. The purposes of this work were to construct a secretable SOD protein using recombinant DNA technics and to evaluate the anti-inflammatory effects of SOD delivered by genetically modified skin fibroblasts and lung epithelial cells in vitro and in vivo.Methods. To secrete SOD protein into extracellular space, we constructed the plasmid with interleukin-2 signal peptide and human SOD (pRc/CMV-ILSOD). Rat skin fibroblasts and lung epithelial cells were transfected with pRc/CMV-ILSOD including secretable SOD-coding cDNA.The effects of host and transformants on oxidativestress using the xanthine/xanthine oxidase (X/XO) system were examined by two in vitro models to study the autocrine and paracrine SOD action. The anti-inflammatory effects by transplantation of host and transformants were evaluated in 3 kinds of acute inflammation models, carrageenin-induced paw edema, liquid nitrogen-induced edema and paraquat induced lung damage, in rats.Results. The transformants (ILSOD cells) se … More creted SOD protein into the extracellular space, and the extracellular SOD activity in ILSOD cells cultures was significantly increased in comparison with that in host cell cultures. ILSOD cells diminished the cytotoxic activity by X/XO,in autocrine and paracrine fashions. These protective effects of ILSOD cells against X/XO-induced cytotoxicity correlated well with the decreaase in lipid peroxidation in the damaged cells. The in vivo study showed that transplantation of ILSOD cell suspensions into the hind paw in rats inhibited carrageenin-induced paw edema for at least 7 days, and the degrff and the durability of these inhibitory effects were dependent on the number of ILSOD cells transplanted. These inhibitory effects of ILSOD cell suspensions were reduced by coadministration of hSOD antiserum. The healing of paw edema caused by carrageenin was markedly enhancec by transplantation of ILSOD cells into the edematous hind paw. And transplantation of ILSOD cell suspensions into the subcutaneous tissue in rats inhibited liquid nitrogen-induced edema. Furthermore, tansplantation of ILSOD cell suspensions into the thorax in rats inhibited liquid paraquat-induced lung damage.Conclusions. The results suggested that genetically modified skin fibroblasts and lung epithelial cells area suitable delivery system for obtaining efficient and continuous supply of SOD at the target site, and this strategy may be useful as a drug delivery system for other therapeutic proteins. Less
目的。本研究目的是利用重组DNA技术构建可分泌SOD蛋白,并在体外和体内评价转基因皮肤成纤维细胞和肺上皮细胞传递SOD的抗炎作用。为了将SOD蛋白分泌到细胞外,我们将白细胞介素-2信号肽和人SOD (pRc/CMV-ILSOD)构建质粒。用pRc/CMV-ILSOD转染大鼠皮肤成纤维细胞和肺上皮细胞,其中含有可分泌的sod编码cDNA。利用黄嘌呤/黄嘌呤氧化酶(X/XO)体系,通过两种体外模型研究了宿主和转化体对氧化应激的影响,研究了自分泌和旁分泌SOD的作用。采用角叉菜胶致大鼠足跖水肿、液氮致大鼠足跖水肿和百草枯致大鼠肺损伤3种急性炎症模型,评价宿主和转化体移植的抗炎作用。转化子(ILSOD细胞)在胞外空间产生了更多的SOD蛋白,与宿主细胞培养相比,ILSOD细胞培养的胞外SOD活性显著提高。ILSOD细胞以自分泌和旁分泌方式通过X/XO降低细胞毒活性。ILSOD细胞对X/ xo诱导的细胞毒性的这些保护作用与受损细胞中脂质过氧化的减少密切相关。体内研究表明,将ILSOD细胞悬浮液移植到大鼠后爪,可以抑制卡拉胶诱导的足跖水肿至少7天,并且这种抑制作用的降解程度和持续时间取决于移植ILSOD细胞的数量。同时加入hSOD抗血清后,ILSOD细胞悬液的抑制作用减弱。将ILSOD细胞移植至肿胀的后爪,可明显促进卡拉胶所致足跖水肿的愈合。ILSOD细胞悬液皮下移植对液氮诱导的水肿有抑制作用。此外,ILSOD细胞悬浮液胸腔移植对百草枯所致大鼠肺损伤有抑制作用。结果表明,基因修饰的皮肤成纤维细胞和肺上皮细胞是获得有效和持续供应的超氧化物歧化酶的合适的递送系统,这种策略可能有助于作为其他治疗性蛋白的药物递送系统。少
项目成果
期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
K.Nishiguchi, K.Ishida, M.Nakajima, T.Maeda, F.Komada, S.Iwakawa, Y.Tanigawara & K.Okumura: "Pharmaceutical Studies for Gene Therapy : Expression of Human Cu, Zn-Superoxide Dismutase Gene Transfected by Lipofection Technique in Rat Skin Fibroblasts." Biol
K.Nishiguchi、K.Ishida、M.Nakajima、T.Maeda、F.Komada、S.Iwakawa、Y.Tanikawara
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K. Nishiguchi, K. Ishida, et al.: "Pharmaceutical Studies for Gene Therapy: Expression of Human Cu, Zn-Superoxide Dismutase Gene Transfected by Lipofection Technique in Rat Skin Fibroblasts." Biol. Pharm. Bull.19. 1073-1077 (1996)
K. Nishiguchi、K. Ishida 等人:“基因治疗的药物研究:通过脂转染技术在大鼠皮肤成纤维细胞中表达人铜、锌超氧化物歧化酶基因。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K. Nishiguchi, K. Ishida, et al.: "Effect of Transfection with the Cu, Zn-Superoxide Dismutase Gene on Xanthine/Xanthine Oxidase-Induced Cytotoxicity in Fibroblasts from Rat Skin." Pharm. Res.13. 575-580 (1996)
K. Nishiguchi、K. Ishida 等人:“铜、锌超氧化物歧化酶基因转染对大鼠皮肤成纤维细胞中黄嘌呤/黄嘌呤氧化酶诱导的细胞毒性的影响”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
F. Komada, K. Nishiguchi, et al.: "Effect of Transfection with Superoxide Dismulase Expression Plasmid on Superoxide Anion Induced Cytotoxicity in Cultured Rat lung Cells." Biol. Pharm. Bull.19. 274-279 (1996)
F. Komada、K. Nishiguchi 等人:“用超氧化物歧化酶表达质粒转染对培养的大鼠肺细胞中超氧化物阴离子诱导的细胞毒性的影响”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
K.Nishiguchi, K.Ishida, M.Nakajima, T.Maeda, F.Komada, S.Iwakawa, Y.Tanigawara & K.Okumura: "Effect of Transfection with the Cu, Zn-Superoxide Dismutase Gene on Xanthine/Xanthine Oxidase-Induced Cytotoxicity in Fibroblasts from Rat Skin." Pharm. Res.13. 5
K.Nishiguchi、K.Ishida、M.Nakajima、T.Maeda、F.Komada、S.Iwakawa、Y.Tanikawara
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
OKUMURA Katsuhiko其他文献
OKUMURA Katsuhiko的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('OKUMURA Katsuhiko', 18)}}的其他基金
Proteomic analysis to discover diagnostic markers in human renal call carcinoma
蛋白质组学分析发现人肾癌的诊断标志物
- 批准号:
19590167 - 财政年份:2007
- 资助金额:
$ 0.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Discovery of targets for treatment with renal cell carcinoma by gene and protein expression profile analysis
通过基因和蛋白质表达谱分析发现肾细胞癌治疗靶点
- 批准号:
16390040 - 财政年份:2004
- 资助金额:
$ 0.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Evaluation of the analytical methods of antisense oligonueleotide applicable to the antisense therapy
适用于反义治疗的反义寡核苷酸分析方法评价
- 批准号:
13672386 - 财政年份:2001
- 资助金额:
$ 0.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Prediction of Pharmacokinetics and Efficacy/Toxicity by Genotypes of Metabolic Enzymes
通过代谢酶基因型预测药代动力学和功效/毒性
- 批准号:
07457558 - 财政年份:1995
- 资助金额:
$ 0.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
PHARMACEUTICAL STUDY FOR GENE THERAPY USING CELL TRANSFECTED WITH HUMAN SOD GENE TO RESPIRATORY DISTRESS SYNOROME
转染人SOD基因的细胞对呼吸窘迫综合征进行基因治疗的药物研究
- 批准号:
04454543 - 财政年份:1992
- 资助金额:
$ 0.9万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Drug Delivery System of Insulin and Calcitonin through the Scrotum of Rats.
胰岛素和降钙素通过大鼠阴囊的药物输送系统。
- 批准号:
62570963 - 财政年份:1987
- 资助金额:
$ 0.9万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Gene expression profiling of skin ulcers for short-acting in vivo gene therapy
皮肤溃疡的基因表达谱用于短效体内基因治疗
- 批准号:
23K19673 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
Grant-in-Aid for Research Activity Start-up
Development of Organ- and Cell-specific In Vivo Genome Editing Technique as a Novel Approach for Cancer Gene Therapy
开发器官和细胞特异性体内基因组编辑技术作为癌症基因治疗的新方法
- 批准号:
23H02763 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Defining the Potential of Gene Therapy to Correct Motor Disabilities of CTNNB1 Syndrome Using in Vivo Mouse and in Vitro Human Cell Models
利用体内小鼠和体外人类细胞模型确定基因疗法纠正 CTNNB1 综合征运动障碍的潜力
- 批准号:
10809254 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
In vivo HSC gene therapy using a multi-modular HDAd vector for HIV cure
使用多模块 HDAd 载体进行体内 HSC 基因治疗以治愈 HIV
- 批准号:
10599503 - 财政年份:2023
- 资助金额:
$ 0.9万 - 项目类别:
Developing a novel in vivo gene therapy intervention for solid tumours by targeting tumour-associated-macrophage plasticity.
通过针对肿瘤相关巨噬细胞的可塑性,开发一种针对实体瘤的新型体内基因治疗干预措施。
- 批准号:
2720553 - 财政年份:2022
- 资助金额:
$ 0.9万 - 项目类别:
Studentship
In-vivo gene therapy for Retinitis Pigmentosa
色素性视网膜炎的体内基因治疗
- 批准号:
10043370 - 财政年份:2022
- 资助金额:
$ 0.9万 - 项目类别:
Grant for R&D
In vivo genome editing efficiency optimization and its application to gene therapy in animal models of disease
体内基因组编辑效率优化及其在疾病动物模型基因治疗中的应用
- 批准号:
18K06040 - 财政年份:2020
- 资助金额:
$ 0.9万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
T cell-targeted lentiviral vectors with Cas9/RNP for the in vivo gene therapy of HIV-AIDS
带有 Cas9/RNP 的 T 细胞靶向慢病毒载体用于 HIV-AIDS 体内基因治疗
- 批准号:
10077829 - 财政年份:2019
- 资助金额:
$ 0.9万 - 项目类别:
T cell-targeted lentiviral vectors with Cas9/RNP for the in vivo gene therapy of HIV-AIDS
带有 Cas9/RNP 的 T 细胞靶向慢病毒载体用于 HIV-AIDS 体内基因治疗
- 批准号:
10322128 - 财政年份:2019
- 资助金额:
$ 0.9万 - 项目类别:
T cell-targeted lentiviral vectors with Cas9/RNP for the in vivo gene therapy of HIV-AIDS
带有 Cas9/RNP 的 T 细胞靶向慢病毒载体用于 HIV-AIDS 体内基因治疗
- 批准号:
9763971 - 财政年份:2019
- 资助金额:
$ 0.9万 - 项目类别:














{{item.name}}会员




